2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O19] Oral Session 19　Translational Research / Clinical Pharmacology
【E】

Sat. Feb 19, 2022 8:20 AM - 9:50 AM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Yuichi Ando（Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital），Yataro Daigo（Department of Medical Oncology and Cancer Center / Center for Antibody and Vaccine Therapy, Institute of Medical Science, Shiga University of Medical Science / The University of Tokyo）
Discussant：Shunsuke Kondo（Department of Experimental Therapeutics, National Cancer Center Hospital）

[O19-6] Dose Selection for DuoBody®-PD-L1x4-1BB (GEN1046) Using a Semimechanistic PK/PD Model Based on Preclinical/Clinical Data

○Gaurav Bajaj5, Fereshteh Nazari2, Marc Presler2, Craig Thalhauser5, Ulf Forssmann3, Maria Jure-Kunkel5, Alexander Muik4, Eleni Lagkadinou4, Özlem Türeci4, Uğur Şahin4, Tahamtan Ahmadi5, Manish Gupta5 (1.Genmab, 2.Applied BioMath LLC, Concord, MA, USA, 3.Genmab A/S, Copenhagen, Denmark, 4.BioNTech SE, Mainz, Germany, 5.Genmab, Princeton, NJ, USA)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password